Cresset Asset Management’s Core Laboratories CLB Stock Holding History

Cresset Asset Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-706	Closed	-$49K	–	693
2019 Q1	$49K	Buy	706 +666	+1,665%	+$44.6K	﹤0.01%	785
2018 Q4	$2K	Buy	+40	New	+$3.45K	﹤0.01%	1282

Other funds holding CLB

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Cresset Asset Management's CLB Position: Q2 2019 in Review

Cresset Asset Management sold out of Core Laboratories (CLB) in Q2 2019, closing a stake of 706 shares — an estimated $49K sold.

Cresset Asset Management first reported a position in CLB in Q4 2018 and held it in 2 quarters. The position peaked at $49K in Q1 2019. 304 funds tracked by Wall St. Rank hold CLB as of Q2 2019.

Cresset Asset Management reported no remaining Core Laboratories position as of Q2 2019 after selling out during the quarter.
Cresset Asset Management sold 706 Core Laboratories shares in Q2 2019, an estimated $49K.
Cresset Asset Management first reported a position in Core Laboratories in Q4 2018 and held it in 2 quarters.
Cresset Asset Management's Core Laboratories position peaked at $49K in Q1 2019.
304 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2019.

Based on Cresset Asset Management's 13F filing for Q2 2019, filed 12 Aug 2019.